Annual ROE
-50.16%
+0.41%+0.81%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual return on equity is currently -50.16%, with the most recent change of +0.41% (+0.81%) on 31 December 2023. During the last 3 years, it has fallen by -6.46% (-14.78%). CRNX annual ROE is now -151.70% below its all-time high of 97.02%, reached on 31 December 2016.CRNX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-36.12%
+6.31%+14.87%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly return on equity is currently -36.12%, with the most recent change of +6.31% (+14.87%) on 30 September 2024. Over the past year, it has increased by +20.86% (+36.61%). CRNX quarterly ROE is now -145.47% below its all-time high of 79.44%, reached on 30 June 2018.CRNX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | +36.6% |
| 3 y3 years | -14.8% | +34.6% |
| 5 y5 years | -196.4% | -22.4% |
CRNX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.7% | +0.8% | at high | +37.6% |
| 5 y | 5 years | -196.4% | +0.8% | -22.4% | +37.6% |
| alltime | all time | -151.7% | +0.8% | -145.5% | +54.1% |
Crinetics Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -36.12%(-14.9%) |
| June 2024 | - | -42.43%(-10.0%) |
| Mar 2024 | - | -47.16%(-14.8%) |
| Dec 2023 | -50.16%(-0.8%) | -55.36%(-2.8%) |
| Sept 2023 | - | -56.98%(-1.6%) |
| June 2023 | - | -57.89%(+8.1%) |
| Mar 2023 | - | -53.53%(+10.3%) |
| Dec 2022 | -50.57%(+17.7%) | -48.53%(+1.5%) |
| Sept 2022 | - | -47.80%(+7.0%) |
| June 2022 | - | -44.67%(-3.6%) |
| Mar 2022 | - | -46.36%(-5.6%) |
| Dec 2021 | -42.98% | -49.13%(-11.0%) |
| Sept 2021 | - | -55.22%(+9.7%) |
| June 2021 | - | -50.32%(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -44.81%(+1.3%) |
| Dec 2020 | -43.70%(+1.5%) | -44.24%(+2.1%) |
| Sept 2020 | - | -43.35%(-3.8%) |
| June 2020 | - | -45.05%(-0.4%) |
| Mar 2020 | - | -45.23%(+25.8%) |
| Dec 2019 | -43.04%(+154.4%) | -35.94%(+21.8%) |
| Sept 2019 | - | -29.51%(-6.1%) |
| June 2019 | - | -31.43%(-10.8%) |
| Mar 2019 | - | -35.25%(-30.4%) |
| Dec 2018 | -16.92%(-127.8%) | -50.67%(-35.7%) |
| Sept 2018 | - | -78.78%(-199.2%) |
| June 2018 | - | 79.44%(+15.7%) |
| Mar 2018 | - | 68.66%(+12.6%) |
| Dec 2017 | 60.96%(-37.2%) | 60.96% |
| Dec 2016 | 97.02% | - |
FAQ
- What is Crinetics Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual ROE year-on-year change?
- What is Crinetics Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly ROE year-on-year change?
What is Crinetics Pharmaceuticals annual return on equity?
The current annual ROE of CRNX is -50.16%
What is the all time high annual ROE for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual return on equity is 97.02%
What is Crinetics Pharmaceuticals annual ROE year-on-year change?
Over the past year, CRNX annual return on equity has changed by +0.41% (+0.81%)
What is Crinetics Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CRNX is -36.12%
What is the all time high quarterly ROE for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly return on equity is 79.44%
What is Crinetics Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CRNX quarterly return on equity has changed by +20.86% (+36.61%)